Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Vitamin D and multiple sclerosis: where do we go from here?
Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
Peripheral neuropathy associated with mitochondrial disease in children.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Secukinumab: first global approval.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.

Pages